• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发弥漫性间变少突胶质细胞瘤患者总生存和癌症特异性生存预测列线图的构建和验证。

Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients with Primary Anaplastic Oligodendroglioma.

机构信息

Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.

出版信息

World Neurosurg. 2024 Jul;187:e472-e484. doi: 10.1016/j.wneu.2024.04.111. Epub 2024 Apr 25.

DOI:10.1016/j.wneu.2024.04.111
PMID:38677647
Abstract

OBJECTIVE

Anaplastic oligodendroglioma (AOD) is a rare high-grade central nervous system tumor. The current research on prognostic prediction of AOD remains limited. This study aimed to identify prognostic factors and establish the nomograms to predict overall survival (OS) and cancer-specific survival (CSS) for patients with AOD.

METHODS

Patients diagnosed with AOD between 1992 and 2020 were extracted from the Surveillance, Epidemiology, and End Result database. We performed univariate and multivariate Cox regression analyses to identify independent prognostic factors based on the training group. Kaplan-Meier survival curves were used to compare the impact of various independent factors on patient prognosis. For OS and CSS, the nomograms were constructed and verified by the validation group. Harrell''s concordance index, receiver operating characteristic curves, calibration curves, and decision curve analyses were used to assess the discrimination, consistency, and clinical value of the nomograms.

RESULTS

A total of 1202 AOD patients were enrolled, being randomly divided into training (n = 841) and validation (n = 361) groups (7:3 ratio). Univariate and multivariate Cox analysis identified 4 significant independent factors (tumor site, age, surgery, and chemotherapy). For OS and CSS, Harrell''s concordance index were 0.731 (0.705-0.757) and 0.728 (0.701-0.754) in the training group, 0.688 (0.646-0.731) and 0.684 (0.639-0.729) in the validation group, respectively. Receiver operating characteristic curves and Calibration curves showed good discrimination and consistency, respectively. In addition, the decision curve analyses curves showed the nomograms have good clinical benefits.

CONCLUSIONS

We successfully established the nomograms to predict the OS and CSS for AOD patients. The nomograms showed good performance in prognostic prediction, assisting clinicians in evaluating patient prognosis and personalizing treatment plans.

摘要

目的

间变性少突胶质细胞瘤(AOD)是一种罕见的高级别中枢神经系统肿瘤。目前关于 AOD 预后预测的研究仍然有限。本研究旨在确定预后因素,并建立列线图来预测 AOD 患者的总生存期(OS)和癌症特异性生存期(CSS)。

方法

从监测、流行病学和最终结果数据库中提取 1992 年至 2020 年间诊断为 AOD 的患者。我们在训练组中进行单变量和多变量 Cox 回归分析,以确定独立的预后因素。Kaplan-Meier 生存曲线用于比较各种独立因素对患者预后的影响。对于 OS 和 CSS,通过验证组构建并验证列线图。Harrell 的一致性指数、接收者操作特征曲线、校准曲线和决策曲线分析用于评估列线图的区分度、一致性和临床价值。

结果

共纳入 1202 例 AOD 患者,随机分为训练组(n=841)和验证组(n=361)(7:3 比例)。单变量和多变量 Cox 分析确定了 4 个显著的独立因素(肿瘤部位、年龄、手术和化疗)。对于 OS 和 CSS,训练组的 Harrell 一致性指数分别为 0.731(0.705-0.757)和 0.728(0.701-0.754),验证组分别为 0.688(0.646-0.731)和 0.684(0.639-0.729)。接收者操作特征曲线和校准曲线分别显示出良好的区分度和一致性。此外,决策曲线分析曲线表明,该列线图具有良好的临床效益。

结论

我们成功建立了预测 AOD 患者 OS 和 CSS 的列线图。该列线图在预后预测方面表现良好,有助于临床医生评估患者的预后并制定个性化的治疗计划。

相似文献

1
Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients with Primary Anaplastic Oligodendroglioma.原发弥漫性间变少突胶质细胞瘤患者总生存和癌症特异性生存预测列线图的构建和验证。
World Neurosurg. 2024 Jul;187:e472-e484. doi: 10.1016/j.wneu.2024.04.111. Epub 2024 Apr 25.
2
Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients.建立并验证梭形细胞肉瘤患者总生存和癌症特异性生存的列线图模型。
Sci Rep. 2023 Dec 27;13(1):23018. doi: 10.1038/s41598-023-50401-z.
3
Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database.基于 SEER 数据库构建并验证预测重新定义的间变性甲状腺癌患者总生存的列线图。
Int J Clin Oncol. 2024 Jun;29(6):744-754. doi: 10.1007/s10147-024-02495-2. Epub 2024 Apr 7.
4
A nomogram to predict postoperative overall and cancer specific survival in patients with primary parotid squamous cell carcinoma: a population based study.预测原发性腮腺鳞状细胞癌患者术后总体生存率和癌症特异性生存率的列线图:一项基于人群的研究。
Sci Rep. 2025 Feb 25;15(1):6774. doi: 10.1038/s41598-025-90480-8.
5
Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.基于人群的回顾性研究:用于评估宫颈神经内分泌癌患者总生存和癌症特异性生存的竞争风险列线图和风险分类系统。
J Endocrinol Invest. 2024 Jun;47(6):1545-1557. doi: 10.1007/s40618-023-02261-7. Epub 2024 Jan 3.
6
Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.不同肿瘤部位早发性结肠癌预后列线图的建立与验证:基于人群的研究。
BMC Gastroenterol. 2023 Oct 21;23(1):362. doi: 10.1186/s12876-023-02991-1.
7
Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.列线图预测 IIIC1 期宫颈癌患者的总生存和癌症特异性生存。
BMC Cancer. 2021 Apr 23;21(1):450. doi: 10.1186/s12885-021-08209-5.
8
Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.基于 SEER 数据库的列线图模型构建与验证:用于预测小肠腺癌患者癌症特异性生存的研究。
World J Surg Oncol. 2024 Jun 7;22(1):151. doi: 10.1186/s12957-024-03438-x.
9
Development of a Nomogram-Based Online Calculator for Predicting Cancer-Specific Survival in Patients With Digestive Tract Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms (MiNENs): An Analysis of the SEER Database.基于列线图的在线计算器的开发,用于预测消化道混合性神经内分泌-非神经内分泌肿瘤(MiNENs)患者的癌症特异性生存率:监测、流行病学和最终结果(SEER)数据库分析
Cancer Rep (Hoboken). 2025 Feb;8(2):e70156. doi: 10.1002/cnr2.70156.
10
Practical Nomograms and Risk Stratification System for Predicting the Overall and Cancer-specific Survival in Patients with Anaplastic Astrocytoma.实用列线图和风险分层系统预测间变性星形细胞瘤患者的总生存期和肿瘤特异性生存期。
World Neurosurg. 2024 Sep;189:e391-e403. doi: 10.1016/j.wneu.2024.06.076. Epub 2024 Jun 21.